temsirolimus
Showing 1 - 25 of 231
Advanced Cancers Trial in Houston (Temsirolimus, Metformin)
Active, not recruiting
- Advanced Cancers
- Temsirolimus
- Metformin
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 11, 2022
High Grade Glioma, Glioma, Glioma, Malignant Trial in Phoenix (Temsirolimus)
Not yet recruiting
- High Grade Glioma
- +3 more
- Temsirolimus
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Mar 6, 2023
Metastatic Renal Cell Carcinoma Trial in Lebanon, Burlington (Sunitinib, Temsirolimus)
Active, not recruiting
- Metastatic Renal Cell Carcinoma
- Sunitinib
- Temsirolimus
-
Lebanon, New Hampshire
- +1 more
Aug 9, 2022
Advanced Cancer Trial in Houston (Temsirolimus, Bevacizumab, Paclitaxel)
Active, not recruiting
- Advanced Cancer
- Temsirolimus
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 11, 2022
Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)
Active, not recruiting
- Brain Tumor, Recurrent
- +4 more
- Cytoreductive surgery
- +2 more
-
New York, New York
- +1 more
Jun 9, 2022
Diffuse Intrinsic Pontine Glioma Trial in Houston (Radiation Therapy, Temsirolimus, Vorinostat)
Active, not recruiting
- Diffuse Intrinsic Pontine Glioma
- Radiation Therapy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 5, 2022
Acute Myeloblastic Leukemia Trial in Germany (sodium chloride solution 0.9%, temsirolimus)
Completed
- Acute Myeloblastic Leukemia
- sodium chloride solution 0.9%
- temsirolimus
-
Berlin, Germany
- +4 more
Nov 10, 2021
Advanced Cancer Trial in Houston (FLT-PET)
Completed
- Advanced Cancer
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 3, 2022
Kidney Cancer Trial in Houston (Pazopanib, Temsirolimus, Quality of Life Assessment)
Completed
- Kidney Cancer
- Pazopanib
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 24, 2021
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,
Completed
- Adult Anaplastic Astrocytoma
- +8 more
- Laboratory Biomarker Analysis
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 28, 2021
Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)
Active, not recruiting
- Advanced Malignant Neoplasm
- +38 more
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Advanced Rare Tumours Trial in Canada (Sunitinib, Temsirolimus)
Active, not recruiting
- Advanced Rare Tumours
- Sunitinib
- Temsirolimus
-
Calgary, Alberta, Canada
- +16 more
Mar 17, 2022
Endometrial Cancer, Ovarian Cancer, Cervical Cancer Trial in Boston (temsirolimus, cediranib)
Completed
- Endometrial Cancer
- +4 more
- temsirolimus
- cediranib
-
Boston, Massachusetts
- +2 more
Apr 20, 2021
Carcinoma, Endometrioid, mTOR Protein Trial in Barcelona, Madrid, Valencia (Temsirolimus)
Completed
- Carcinoma, Endometrioid
- mTOR Protein
- Temsirolimus
-
Barcelona, Spain
- +2 more
Nov 25, 2020
Hepatocellular Carcinoma Trial in San Francisco, Chicago (Temsirolimus, Sorafenib:)
Completed
- Hepatocellular Carcinoma
- Temsirolimus
- Sorafenib:
-
San Francisco, California
- +1 more
Nov 12, 2020
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Rochester, Madison (CCI-779,
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
-
Rochester, Minnesota
- +1 more
Jan 12, 2022
Renal Cell Carcinoma, Nonclear Cell, Temsirolimus Resistance Trial in Seoul (Axitinib)
Completed
- Renal Cell Carcinoma
- +2 more
-
Seoul, Korea, Republic ofSeou National University Hospital
Dec 4, 2020
Hodgkin's Lymphoma Trial in Maywood (Temsirolimus)
Terminated
- Hodgkin's Lymphoma
- Temsirolimus
-
Maywood, IllinoisLoyola Univeristy Medical Center, Cardinal Bernardin Cancer Cent
Sep 14, 2020
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Olaparib
- +13 more
-
Edmonton, Alberta, Canada
- +9 more
Jan 9, 2023
Peripheral Arterial Disease Trial in United States (Temsirolimus, Temsirolimus and dexamethasone sodium phosphate)
Recruiting
- Peripheral Arterial Disease
- Temsirolimus
- Temsirolimus and dexamethasone sodium phosphate
-
Little Rock, Arkansas
- +10 more
Aug 31, 2020
Advanced Cancer, Solid Tumor Trial in Houston (Vemurafenib, Everolimus, Temsirolimus)
Completed
- Advanced Cancer
- Solid Tumor
- Vemurafenib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 1, 2020